Targeted depletion of TRBV9+ T cells as immunotherapy in a patient with ankylosing spondylitis

Researchers from Skoltech contributed to a large study made by colleagues from Pirogov Russian National Research Medical University, Shemyakin-Ovchinnikov Institute of bioorganic chemistry and other universities and organizations. The article, published in the Nature Medicine journal, presents an innovative treatment for ankylosing spondylitis.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup